local_hospital

Clinic of Clinical Pharmacology and Therapeutics UMHAT 'Tsaritsa Ioanna-ISUL' EAD

Address
lock Available on a paid plan

Congenital, Hereditary, and Neonatal Diseases

The Clinic of Clinical Pharmacology and Therapeutics is advancing research on rare genetic conditions, aiming to develop new therapeutic strategies and deepen knowledge of disease mechanisms.

  • Adult polyglucosan body disease
  • Genetic metabolic pathways
  • Early‑life disease biomarkers

Innovative pharmacological assessments are incorporated to support future treatments for inherited disorders.

Respiratory Tract Diseases

Studies focus on airway disorders, evaluating inhaled device performance and safety in healthy volunteers to guide therapy optimization.

  • Tiotropium inhaler equivalence
  • Lung function testing
  • Device delivery consistency

Results contribute to the development of reliable respiratory medicines and improve patient dosing accuracy.

Bioequivalence & Pharmacokinetics

The site specializes in comparative studies of drug absorption and safety, supporting regulatory decisions and market access for generic products.

  • Ibuprofen bioequivalence
  • Cladribine comparative study
  • Pharmacokinetic profiling

These investigations help ensure therapeutic equivalence and promote cost‑effective treatment options.

Site Overview

assignment
7
connected trials
corporate_fare
6
sponsors
science
0
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
7
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
6
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 476 other sites in Bulgaria

description
Trial volume
7
Outperforms 64% of sites
public
Therapeutic diversity
5areas
Outperforms 78% of sites
groups
Sponsor diversity
6sponsors
Outperforms 68% of sites

Therapeutic Area Benchmark — Bulgaria

Select a therapeutic area to compare against other sites in Bulgaria.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Bulgaria

Market Share

Country: Bulgaria

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Clinic of Clinical Pharmacology and Therapeutics UMHAT 'Tsaritsa Ioanna-ISUL' EAD

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Bioequivalence Study of 600 mg Ibuprofen: Comparison of Ibuprofen Sopharma and Brufen in a Monocentric, Open, Randomized, Crossover Trial in Healthy VolunteersCCDRD Cooperative Clinical Drug Research and Development AG, Sopharma ADPhase INot RecruitingSep 2025Oct 2025

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.